Definition, type, frequency and prognostic impact of anaemia in chronic heart failure

European Journal of Heart Failure, Supplement

Volumn 2, Issue 2, 2003, Pages 217-220

  Anker, Stefan D ^a,b   Steinborn, Wolfram ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Anaemia; Chronic heart failure; Mortality; Pathophysiology

Indexed keywords

HEMOGLOBIN;

ANEMIA; ARTICLE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 12144250626     PISSN: 15674215     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-4215(03)80006-1     Document Type: Article

References (24)

1. McMurray J.J., and Stewart J. Epidemiology, aetiology, and prognosis of heart failure. Heart 833 (2000) 596-602
2. Cleland J.G., Cohen-Solal A., Aguilar J.C., Dietz R., Eastaugh J., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360 (2002) 1631-1639
3. Silverberg D.S., Wexler D., Blum M., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anaemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalisations. J Am Coll Cardiol 35 (2000) 1737-1744
4. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anaemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomised controlled study. J Am Coll Cardiol 37 (2001) 1775-1780
5. Wisniacki N., Aimson P., and Lyle M. Is anemia a cause of heart failure in the elderly?. Heart 85 Suppl I (2001) P4 (abstract)
6. Cromie N., Lee C., and Struthers A.D. Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes?. Heart 87 (2002) 377-378
7. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes. Insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
8. Pitt B., Poole-Wilson P.A., Segal R., Martinez F.A., Dickstein K., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 355 (2000) 1582-1587
9. Anker S.D., Sharma R., Francis D.F., Pitt B., Poole-Wilson P.A., and Coats A.J.S. Hemoglobin predicts survival in patients with chronic heart failure with a U-shaped curve: a substudy of the ELITE II trial. Eur Heart J 23 (2002) 447 (abstract)
10. Chatterjee B., Nydegger U.E., and Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT1 antagonists. Eur J Heart Fail 2 (2000) 393-398
11. Ponikowski P., Francis D.P., Piepoli M.F., et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 103 (2001) 967-972
12. Kalra P.R., Bolgen A.P., Sharma R., et al. The relationship between haemoglobin and exercise capacity in patients with stable chronic heart failure. Am J Cardiol (2003) (in press)
13. Al-Ahmad A., Rand S.M., Manjunath G., et al. Reduced kidney function and anaemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
14. Anker S.D., Sharma R., Francis D., Pitt B., Poole-Wilson P.A., and Coats A.J.S. Anaemia and survival in 3044 patients with chronic heart failure (CHF) in the ELITE II trial. Circulation 106 (2002) II-472 (abstract)
15. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., and Borenstein J. Anaemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
16. Anand I.S., Chandrashekhar Y., Ferrari R., Poole-Wilson P.A., and Harris P.C. Pathogenesis of edema in chronic anemia: studies of body water and sodium, renal function, haemodynamics and plasma hormones. Br Heart J 70 (1993) 357-362
17. Iverson P.O., Wolbaek P.R., Tonnessen T., and Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol 282 (2002) R166-R172
18. Witte K.K., and Clark A.L. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol 85 (2002) 23-31
19. Anker S.D., and Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 85 (2002) 51-66
20. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
21. Torre-Amione G., Bozkurt B., Deswal A., and Mann D.L. An overview of tumor necrosis factor and the failing human heart. Curr Opin Cardiol 14 (1999) 1836-1841
22. Silagy C.A., McNeil J.J., Donnan G.A., Tonkin A.M., Worsam B., and Campion K. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 54 (1993) 84-89
23. Kalra P.R., Anagnostopoulos C., Bolger A.P., Coats A.J., and Anker S.D. The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39 (2002) 1901-1908
24. Androne A.S., Katz S.D., Lund L., et al. Hemodilution is common in patients with advanced heart failure. Circulation 107 (2003) 226-229